+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pain Management Drugs Market Forecast to 2033

  • PDF Icon

    Report

  • 150 Pages
  • October 2025
  • Region: Global
  • Grand View Research
  • ID: 6189435
REQUEST CUSTOMIZATION
Description Jump to:
The global pain management drugs market size was estimated at USD 78.84 billion in 2024 and is projected to reach USD 115.92 billion by 2033, growing at a CAGR of 4.38% from 2025 to 2033. The rising prevalence of chronic pain conditions across aging and lifestyle-affected populations drives the growth of the global pain management drugs market.

Increasing cases of arthritis, cancer-related pain, lower back disorders, neuropathic pain, and post-surgical discomfort have intensified the demand for effective pharmacological interventions. The growing burden of musculoskeletal and neurological disorders has expanded the patient pool requiring long-term pain therapy. Healthcare providers are adopting advanced pain management approaches to enhance quality of life and reduce healthcare burden. In addition, the growing awareness of pain as a treatable clinical condition has supported early diagnosis and treatment. The rising number of surgical procedures globally further contributes to the higher consumption of analgesics and opioids, strengthening the need for targeted and multimodal pain management therapies.

The market expansion is further supported by continuous innovation in non-opioid pain medications and novel drug delivery technologies. For instance, in January 2025, TIME reported that the U.S. Food and Drug Administration (FDA) approved suzetrigine, marketed as Journavx by Vertex Pharmaceuticals, as the first new class of non-opioid pain medication in over 20 years. Suzetrigine is a 50 mg oral tablet taken twice daily and targets the Nav1.8 sodium channel, specific to pain neurons, thereby avoiding the addictive potential of opioids. In clinical trials involving patients recovering from bunionectomy and abdominoplasty surgeries, 83% and 61% of participants taking suzetrigine, respectively, reported at least a 30% reduction in pain, compared to 68% and 48% in the placebo groups. These results suggest that suzetrigine may offer a safer alternative to opioids for managing acute pain. Pharmaceutical companies also focus on developing safer formulations, while advancements in extended-release and transdermal drugs improve efficacy, convenience, and patient adherence.

Regulatory oversight continues to shape market trends. For instance, on March 12, 2025, the UK Medicines and Healthcare products Regulatory Agency (MHRA) and the Commission on Human Medicines (CHM) published a report detailing the removal of the post-operative pain indication from all modified-release opioids due to safety concerns, including persistent post-operative opioid use (PPOU) and opioid-induced ventilatory impairment (OIVI). PPOU occurred in 2% to 44% of patients treated with prolonged-release opioids, rising to 60% in those previously using these opioids, while OIVI incidence ranged from 0.4% to 41%. Consequently, the MHRA recommended that only immediate-release opioids be prescribed for short-term post-operative pain and encouraged smaller pack sizes to reduce over-prescription. Overall, growing R&D in non-addictive analgesics, personalized therapies, digital monitoring tools, and expanded healthcare access is fueling the sustained growth of the pain management drugs market globally.

Global Pain Management Drugs Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global pain management drugs market report based on drug class, indication, distribution channel and region:

Drug Class Outlook (Revenue, USD Million, 2021-2033)

  • NSAIDs
  • Opioids
  • Anesthetics
  • Antidepressants
  • Anticonvulsants
  • Others

Indication Outlook (Revenue, USD Million, 2021-2033)

  • Acute Pain (Postoperative, Injury-Related, Musculoskeletal)
  • Chronic Musculoskeletal Pain / Osteoarthritis / Low Back Pain
  • Neuropathic Pain (Diabetic Neuropathy, Postherpetic Neuralgia, Fibromyalgia)
  • Migraine (Acute & Preventive)
  • Cancer Pain
  • Post-Surgical / Hospital-Based Procedural Pain (short duration)
  • Others

Distribution Channel Outlook (Revenue, USD Million, 2021-2033)

  • Online Pharmacy
  • Retail Pharmacy
  • Hospital Pharmacy

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Report Deliverables

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug Class
1.2.2. Indication
1.2.3. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Pain Management Drugs Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Pricing Analysis
Chapter 4. Pain Management Drugs Market: Drug Class Business Analysis
4.1. Drug Class Market Share, 2024 & 2033
4.2. Drug Class Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
4.4. NSAIDs
4.4.1. NSAIDs Market, 2021-2033 (USD Million)
4.5. Opioids
4.5.1. Opioids Market, 2021-2033 (USD Million)
4.6. Anesthetics
4.6.1. Anesthetics Market, 2021-2033 (USD Million)
4.7. Antidepressants
4.7.1. Antidepressants Market, 2021-2033 (USD Million)
4.8. Anticonvulsants
4.8.1. Anticonvulsants Market, 2021-2033 (USD Million)
4.9. Others
4.9.1. Others Market, 2021-2033 (USD Million)
Chapter 5. Pain Management Drugs Market: Indication Business Analysis
5.1. Indication Market Share, 2024 & 2033
5.2. Indication Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Indication, 2021 to 2033 (USD Million)
5.4. Acute Pain (Postoperative, Injury-Related, Musculoskeletal)
5.4.1. Acute Pain (Postoperative, Injury-Related, Musculoskeletal) Market, 2021-2033 (USD Million)
5.5. Chronic Musculoskeletal Pain / Osteoarthritis / Low Back Pain
5.5.1. Chronic Musculoskeletal Pain / Osteoarthritis / Low Back Pain Market, 2021-2033 (USD Million)
5.6. Neuropathic Pain (Diabetic Neuropathy, Postherpetic Neuralgia, Fibromyalgia)
5.6.1. Neuropathic Pain (Diabetic Neuropathy, Postherpetic Neuralgia, Fibromyalgia) Market, 2021-2033 (USD Million)
5.7. Migraine (Acute & Preventive)
5.7.1. Migraine (Acute & Preventive) Market, 2021-2033 (USD Million)
5.8. Cancer Pain
5.8.1. Cancer Pain Market, 2021-2033 (USD Million)
5.9. Post-Surgical / Hospital-Based Procedural Pain (short duration)
5.9.1. Post-Surgical / Hospital-Based Procedural Pain (short duration) Market, 2021-2033 (USD Million)
5.10. Others
5.10.1. Others Market, 2021-2033 (USD Million)
Chapter 6. Pain Management Drugs Market: Distribution Channel Business Analysis
6.1. Distribution Channel Market Share, 2024 & 2033
6.2. Distribution Channel Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
6.4. Online Pharmacy
6.4.1. Online Pharmacy Market, 2021-2033 (USD Million)
6.5. Retail Pharmacy
6.5.1. Retail Pharmacy Market, 2021-2033 (USD Million)
6.6. Hospital Pharmacy
6.6.1. Hospital Pharmacy Market, 2021-2033 (USD Million)
Chapter 7. Pain Management Drugs Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2033
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
7.4. North America
7.4.1. North America Pain Management Drugs Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Regulatory Framework
7.4.2.4. Reimbursement Framework
7.4.2.5. U.S. Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Regulatory Framework
7.4.3.4. Reimbursement Framework
7.4.3.5. U.S. Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Regulatory Framework
7.4.4.4. Reimbursement Framework
7.4.4.5. Mexico Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5. Europe
7.5.1. Europe Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement Framework
7.5.2.5. Uk Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement Framework
7.5.3.5. Germany Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement Framework
7.5.4.5. France Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Regulatory Framework
7.5.5.4. Reimbursement Framework
7.5.5.5. Italy Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Target Disease Prevalence
7.5.6.3. Regulatory Framework
7.5.6.4. Reimbursement Framework
7.5.6.5. Spain Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Target Disease Prevalence
7.5.7.3. Regulatory Framework
7.5.7.4. Reimbursement Framework
7.5.7.5. Denmark Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Target Disease Prevalence
7.5.8.3. Regulatory Framework
7.5.8.4. Reimbursement Framework
7.5.8.5. Sweden Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Target Disease Prevalence
7.5.9.3. Regulatory Framework
7.5.9.4. Reimbursement Framework
7.5.9.5. Norway Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6. Asia-Pacific
7.6.1. Asia-Pacific Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement Framework
7.6.2.5. Japan Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement Framework
7.6.3.5. China Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement Framework
7.6.4.5. India Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement Framework
7.6.5.5. Australia Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement Framework
7.6.6.5. South Korea Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Target Disease Prevalence
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement Framework
7.6.7.5. Thailand Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7. Latin America
7.7.1. Latin America Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Target Disease Prevalence
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement Framework
7.7.2.5. Japan Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Target Disease Prevalence
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement Framework
7.7.3.5. China Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8. Middle East and Africa
7.8.1. Middle East and Africa Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Target Disease Prevalence
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement Framework
7.8.2.5. South Africa Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Target Disease Prevalence
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement Framework
7.8.3.5. Saudi Arabia Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Target Disease Prevalence
7.8.4.3. Regulatory Framework
7.8.4.4. Reimbursement Framework
7.8.4.5. UAE Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Target Disease Prevalence
7.8.5.3. Regulatory Framework
7.8.5.4. Reimbursement Framework
7.8.5.5. Kuwait Pain Management Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Teva Pharmaceutical
8.5.1.1. Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Pfizer
8.5.2.1. Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Abbott
8.5.3.1. Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Mallinckrodt Pharmaceuticals
8.5.4.1. Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Endo International
8.5.5.1. Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. GlaxoSmithKline
8.5.6.1. Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. AstraZeneca
8.5.7.1. Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Depomed
8.5.8.1. Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. Merck
8.5.9.1. Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Novartis
8.5.10.1. Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global pain management drugs market, by region, 2021-2033 (USD Million)
Table 4 Global pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 5 Global pain management drugs market, by indication, 2021-2033 (USD Million)
Table 6 Global pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 7 North America pain management drugs market, by country, 2021-2033 (USD Million)
Table 8 North America pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 9 North America pain management drugs market, by indication, 2021-2033 (USD Million)
Table 10 North America pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 11 U.S. pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 12 U.S. pain management drugs market, by indication, 2021-2033 (USD Million)
Table 13 U.S. pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 14 Canada pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 15 Canada pain management drugs market, by indication, 2021-2033 (USD Million)
Table 16 Canada pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 17 Mexico pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 18 Mexico pain management drugs market, by indication, 2021-2033 (USD Million)
Table 19 Mexico pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 20 Europe pain management drugs market, by country, 2021-2033 (USD Million)
Table 21 Europe pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 22 Europe pain management drugs market, by indication, 2021-2033 (USD Million)
Table 23 Europe pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 24 UK pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 25 UK pain management drugs market, by indication, 2021-2033 (USD Million)
Table 26 UK pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 27 Germany pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 28 Germany pain management drugs market, by indication, 2021-2033 (USD Million)
Table 29 Germany pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 30 France pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 31 France pain management drugs market, by indication, 2021-2033 (USD Million)
Table 32 France pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 33 Italy pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 34 Italy pain management drugs market, by indication, 2021-2033 (USD Million)
Table 35 Italy pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 36 Spain pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 37 Spain pain management drugs market, by indication, 2021-2033 (USD Million)
Table 38 Spain pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 39 Norway pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 40 Norway pain management drugs market, by indication, 2021-2033 (USD Million)
Table 41 Norway pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 42 Denmark pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 43 Denmark pain management drugs market, by indication, 2021-2033 (USD Million)
Table 44 Denmark pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 45 Sweden pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 46 Sweden pain management drugs market, by indication, 2021-2033 (USD Million)
Table 47 Sweden pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 48 Asia-Pacific pain management drugs market, by country, 2021-2033 (USD Million)
Table 49 Asia-Pacific pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 50 Asia-Pacific pain management drugs market, by indication, 2021-2033 (USD Million)
Table 51 Asia-Pacific pain management drugs market, by distribution channel, 2021-2033 (USD
Table 52 Japan pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 53 Japan pain management drugs market, by indication, 2021-2033 (USD Million)
Table 54 Japan pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 55 China pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 56 China pain management drugs market, by indication, 2021-2033 (USD Million)
Table 57 China pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 58 India pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 59 India pain management drugs market, by indication, 2021-2033 (USD Million)
Table 60 India pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 61 Australia pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 62 Australia pain management drugs market, by indication, 2021-2033 (USD Million)
Table 63 Australia pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 64 South Korea pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 65 South Korea pain management drugs market, by indication, 2021-2033 (USD Million)
Table 66 South Korea pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 67 Thailand pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 68 Thailand pain management drugs market, by indication, 2021-2033 (USD Million)
Table 69 Thailand pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 70 Latin America pain management drugs market, by country, 2021-2033 (USD Million)
Table 71 Latin America pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 72 Latin America pain management drugs market, by indication, 2021-2033 (USD Million)
Table 73 Latin America pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 74 Brazil pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 75 Brazil pain management drugs market, by indication, 2021-2033 (USD Million)
Table 76 Brazil pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 77 Argentina pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 78 Argentina pain management drugs market, by indication, 2021-2033 (USD Million)
Table 79 Argentina pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 80 Middle East & Africa Pain management drugs market, by country, 2021-2033 (USD Million)
Table 81 Middle East & Africa pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 82 Middle East & Africa pain management drugs market, by indication, 2021-2033 (USD Million)
Table 83 Middle East & Africa pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 84 South Africa pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 85 South Africa pain management drugs market, by indication, 2021-2033 (USD Million)
Table 86 South Africa pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 87 Saudi Arabia pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 88 Saudi Arabia pain management drugs market, by indication, 2021-2033 (USD Million)
Table 89 Saudi Arabia pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 90 UAE pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 91 UAE pain management drugs market, by indication, 2021-2033 (USD Million)
Table 92 UAE pain management drugs market, by distribution channel, 2021-2033 (USD Million)
Table 93 Kuwait pain management drugs market, by drug class, 2021-2033 (USD Million)
Table 94 Kuwait pain management drugs market, by indication, 2021-2033 (USD Million)
Table 95 Kuwait pain management drugs market, by distribution channel, 2021-2033 (USD Million)
List of Figures
Figure 1 Pain management drugs market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Therapeutic approach and drug class outlook (USD Million)
Figure 10 Competitive landscape
Figure 11 Pain management drugs market dynamics
Figure 12 Pain management drugs market: Porter’s five forces analysis
Figure 13 Pain management drugs market: PESTLE analysis
Figure 14 Drug class market, 2021-2033 (USD Million)
Figure 15 NSAIDs market, 2021-2033 (USD Million)
Figure 16 Opioids market, 2021-2033 (USD Million)
Figure 17 Anesthetics market, 2021-2033 (USD Million)
Figure 18 Antidepressants market, 2021-2033 (USD Million)
Figure 19 Anticonvulsants market, 2021-2033 (USD Million)
Figure 20 Others market, 2021-2033 (USD Million)
Figure 21 Indication market, 2021-2033 (USD Million)
Figure 22 Acute Pain (Postoperative, Injury-Related, Musculoskeletal) market, 2021-2033 (USD Million)
Figure 23 Chronic Musculoskeletal Pain / Osteoarthritis / Low Back Pain market, 2021-2033 (USD Million)
Figure 24 Neuropathic Pain (Diabetic Neuropathy, Postherpetic Neuralgia, Fibromyalgia) market, 2021-2033 (USD Million)
Figure 25 Migraine (Acute & Preventive) market, 2021-2033 (USD Million)
Figure 26 Cancer Pain market, 2021-2033 (USD Million)
Figure 27 Post-Surgical / Hospital-Based Procedural Pain (short duration) market, 2021-2033 (USD Million)
Figure 28 Others market, 2021-2033 (USD Million)
Figure 29 Distribution channel market, 2021-2033 (USD Million)
Figure 30 Online pharmacy market, 2021-2033 (USD Million)
Figure 31 Retail pharmacy market, 2021-2033 (USD Million)
Figure 32 Hospital pharmacy market, 2021-2033 (USD Million)
Figure 33 Pain management drugs market revenue, by region
Figure 34 Regional marketplace: Key takeaways
Figure 35 North America pain management drugs market, 2021-2033 (USD Million)
Figure 36 U.S. country dynamics
Figure 37 U.S. pain management drugs market, 2021-2033 (USD Million)
Figure 38 Canada country dynamics
Figure 39 Canada pain management drugs market, 2021-2033 (USD Million)
Figure 40 Mexico country dynamics
Figure 41 Mexico pain management drugs market, 2021-2033 (USD Million)
Figure 42 Europe pain management drugs market, 2021-2033 (USD Million)
Figure 43 UK country dynamics
Figure 44 UK pain management drugs market, 2021-2033 (USD Million)
Figure 45 Germany country dynamics
Figure 46 Germany pain management drugs market, 2021-2033 (USD Million)
Figure 47 France country dynamics
Figure 48 France pain management drugs market, 2021-2033 (USD Million)
Figure 49 Italy country dynamics
Figure 50 Italy pain management drugs market, 2021-2033 (USD Million)
Figure 51 Spain country dynamics
Figure 52 Spain pain management drugs market, 2021-2033 (USD Million)
Figure 53 Norway country dynamics
Figure 54 Norway pain management drugs market, 2021-2033 (USD Million)
Figure 55 Sweden country dynamics
Figure 56 Sweden pain management drugs market, 2021-2033 (USD Million)
Figure 57 Denmark country dynamics
Figure 58 Denmark pain management drugs market, 2021-2033 (USD Million)
Figure 59 Asia-Pacific pain management drugs market, 2021-2033 (USD Million)
Figure 60 Japan country dynamics
Figure 61 Japan pain management drugs market, 2021-2033 (USD Million)
Figure 62 China country dynamics
Figure 63 China pain management drugs market, 2021-2033 (USD Million)
Figure 64 India country dynamics
Figure 65 India pain management drugs market, 2021-2033 (USD Million)
Figure 66 Australia country dynamics
Figure 67 Australia pain management drugs market, 2021-2033 (USD Million)
Figure 68 South Korea country dynamics
Figure 69 South Korea pain management drugs market, 2021-2033 (USD Million)
Figure 70 Thailand country dynamics
Figure 71 Thailand pain management drugs market, 2021-2033 (USD Million)
Figure 72 Latin America pain management drugs market, 2021-2033 (USD Million)
Figure 73 Brazil country dynamics
Figure 74 Brazil pain management drugs market, 2021-2033 (USD Million)
Figure 75 Argentina country dynamics
Figure 76 Argentina pain management drugs market, 2021-2033 (USD Million)
Figure 77 MEA pain management drugs market, 2021-2033 (USD Million)
Figure 78 South Africa country dynamics
Figure 79 South Africa pain management drugs market, 2021-2033 (USD Million)
Figure 80 Saudi Arabia country dynamics
Figure 81 Saudi Arabia pain management drugs market, 2021-2033 (USD Million)
Figure 82 UAE country dynamics
Figure 83 UAE pain management drugs market, 2021-2033 (USD Million)
Figure 84 Kuwait country dynamics
Figure 85 Kuwait pain management drugs market, 2021-2033 (USD Million)
Figure 86 Company categorization
Figure 87 Company market position analysis
Figure 88 Strategic framework

Companies Mentioned

The companies profiled in this Pain Management Drugs market report include:
  • Teva Pharmaceutical
  • Pfizer
  • Abbott
  • Mallinckrodt Pharmaceuticals
  • Endo International
  • GlaxoSmithKline
  • AstraZeneca
  • Depomed
  • Merck
  • Novartis

Table Information

Report AttributeDetails
No. of Pages150
PublishedOctober 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 78.84 Billion
Forecasted Market Value ( USD ) by 2033 $ 115.92 Billion
Compound Annual Growth Rate4.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Pain Management Drugs Market Report by Drug Class, Indication, Distribution Channel, and Region 2025-2033 - Product Image

Pain Management Drugs Market Report by Drug Class, Indication, Distribution Channel, and Region 2025-2033

  • Report
  • 149 Pages
  • Global
From
Post-operative Pain Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025-2033 - Product Image

Post-operative Pain Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025-2033

  • Report
  • 171 Pages
  • Global
From
Opioids Market Report by Product Type, Application, Distribution Channel, and Region 2025-2033 - Product Image

Opioids Market Report by Product Type, Application, Distribution Channel, and Region 2025-2033

  • Report
  • 148 Pages
  • Global
From
Analgesics Market Size, Share, Trends, and Forecast by Type, Drug Class, Route of Administration, Pain Type, Application, and Region, 2025-2033 - Product Image

Analgesics Market Size, Share, Trends, and Forecast by Type, Drug Class, Route of Administration, Pain Type, Application, and Region, 2025-2033

  • Report
  • 134 Pages
  • Global
From
Topical Pain Relief Market Size, Share, Trends and Forecast by Therapeutic Class, Formulation, Type, Distribution Channel, and Region, 2025-2033 - Product Image

Topical Pain Relief Market Size, Share, Trends and Forecast by Therapeutic Class, Formulation, Type, Distribution Channel, and Region, 2025-2033

  • Report
  • 143 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.